Medicare Enrolled
Dr. Charisse Barta, M.D.
Neurology · Plano, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Barta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Barta?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Barta
Dr. Charisse Barta is a neurology specialist in Plano, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Barta performed 10,576 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Barta received a total of $21,829 from 99 pharmaceutical and/or device companies across 1068 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Barta is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 8% volume in TX
$21,829 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗10,576
Medicare services
Top 8% in TX for neurology
Not available
Unique patients (not deduplicated)
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
9,200 | $5 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
723 | $84 | $219 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
143 | $132 | $294 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
124 | $74 | $187 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
88 | $108 | $247 |
| New patient office visit, complex (60-74 min) | 80 | $162 | $308 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
51 | $154 | $568 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
48 | $61 | $209 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
38 | $116 | $1,000 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
37 | $127 | $550 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
22 | $154 | $650 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
22 | $100 | $308 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$21,829
Total received (2018-2024)
Avg $3,118/year across 7 years
Top 16% in TX for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
99
Companies
1,068
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,555
2023
$3,675
2022
$2,645
2021
$3,194
2020
$3,140
2019
$2,652
2018
$2,966
Payments by company (2024)
ABBVIE INC.
$680
Abbott Laboratories
$382
EMD Serono, Inc.
$168
ARGENX US, INC.
$130
GENZYME CORPORATION
$129
UCB, Inc.
$128
PFIZER INC.
$123
SK Life Science, Inc.
$117
Lilly USA, LLC
$111
Alexion Pharmaceuticals, Inc.
$97
Genentech USA, Inc.
$93
Merz Pharmaceuticals, LLC
$86
Eisai Inc.
$85
Lundbeck LLC
$82
Amgen Inc.
$80
Sumitomo Pharma America, Inc.
$76
TG Therapeutics, Inc.
$74
Celgene Corporation
$71
Otsuka America Pharmaceutical, Inc.
$68
Amneal Pharmaceuticals LLC
$64
Takeda Pharmaceuticals U.S.A., Inc.
$61
Boston Scientific Corporation
$60
Biogen, Inc.
$54
SCILEX PHARMACEUTICALS INC.
$54
Teva Pharmaceuticals USA, Inc.
$50
Novartis Pharmaceuticals Corporation
$49
Azurity Pharmaceuticals, Inc.
$40
GE HEALTHCARE
$37
JAZZ PHARMACEUTICALS INC.
$34
Kyowa Kirin, Inc.
$29
Aucta Pharmaceuticals, Inc.
$28
Neurocrine Biosciences, Inc.
$27
Vanda Pharmaceuticals Inc.
$23
Kedrion Biopharma, Inc.
$21
Octapharma USA, Inc.
$19
MITSUBISHI TANABE PHARMA AMERICA, INC.
$18
E.R. Squibb & Sons, L.L.C.
$17
SpringWorks Therapeutics, Inc.
$17
Inspire Medical Systems, Inc.
$15
Mallinckrodt Hospital Products Inc.
$15
Life Molecular Imaging Ltd
$14
AstraZeneca Pharmaceuticals LP
$14
Grifols USA, LLC
$13
Top 3 companies account for 34.6% of 2024 payments
All-time payments by company (2018-2024) ›
Alexion Pharmaceuticals, Inc.
$1,171
ABBVIE INC.
$1,006
AbbVie Inc.
$996
EMD Serono, Inc.
$990
Biogen, Inc.
$953
Novartis Pharmaceuticals Corporation
$858
UCB, Inc.
$839
Genentech USA, Inc.
$819
Teva Pharmaceuticals USA, Inc.
$735
Sunovion Pharmaceuticals Inc.
$690
GENZYME CORPORATION
$671
Amgen Inc.
$657
Abbott Laboratories
$604
Lilly USA, LLC
$563
Adamas Pharmaceuticals, Inc.
$458
Lundbeck LLC
$456
ACADIA Pharmaceuticals Inc
$453
Allergan, Inc.
$435
Grifols USA, LLC
$433
Supernus Pharmaceuticals, Inc.
$382
SK Life Science, Inc.
$380
Avanir Pharmaceuticals, Inc.
$360
ARGENX US, INC.
$320
Merz Pharmaceuticals, LLC
$303
PFIZER INC.
$281
Takeda Pharmaceuticals U.S.A., Inc.
$278
Neurocrine Biosciences, Inc.
$273
Celgene Corporation
$247
Amneal Pharmaceuticals LLC
$222
UPSHER-SMITH LABORATORIES LLC
$220
Microtransponder, Inc.
$220
Eisai Inc.
$216
Alnylam Pharmaceuticals Inc.
$212
AbbVie, Inc.
$201
Kyowa Kirin, Inc.
$171
Janssen Pharmaceuticals, Inc
$167
Otsuka America Pharmaceutical, Inc.
$163
Upsher-Smith Laboratories LLC
$159
Biohaven Pharmaceuticals, Inc.
$142
Boston Scientific Corporation
$133
Bausch Health US, LLC
$132
Sumitomo Pharma America, Inc.
$125
Acorda Therapeutics, Inc
$121
Biohaven Pharmaceutical Holding Company Ltd.
$111
US WorldMeds, LLC
$109
CSL Behring
$109
Octapharma USA, Inc.
$107
Allergan Inc.
$103
MERZ NORTH AMERICA, INC.
$102
MITSUBISHI TANABE PHARMA AMERICA, INC.
$95
ARBOR PHARMACEUTICALS, INC.
$87
E.R. Squibb & Sons, L.L.C.
$76
TG Therapeutics, Inc.
$74
Horizon Therapeutics plc
$70
Mallinckrodt Enterprises LLC
$69
GE HEALTHCARE
$65
Greenwich Biosciences, Inc.
$65
JAZZ PHARMACEUTICALS INC.
$64
Assertio Therapeutics, Inc.
$56
SCILEX PHARMACEUTICALS INC.
$54
AstraZeneca Pharmaceuticals LP
$51
ASSERTIO THERAPEUTICS, Inc.
$48
MDD US Operations, LLC
$44
Egalet US Inc
$43
BOSTON SCIENTIFIC CORPORATION
$43
Currax Pharmaceuticals LLC
$43
IMPEL PHARMACEUTICALS INC.
$43
Aprecia Pharmaceuticals, LLC
$43
EISAI INC.
$42
AQUESTIVE THERAPEUTICS, INC.
$42
Azurity Pharmaceuticals, Inc.
$40
Life Molecular Imaging Ltd
$39
Zyla Life Sciences, Inc.
$37
Bayer HealthCare Pharmaceuticals Inc.
$36
Neurelis, Inc.
$36
Merz North America, Inc.
$35
Validus Pharmaceuticals LLC
$34
Zyla Life Sciences
$34
Promius Pharma LLC
$32
GE Healthcare
$32
Mallinckrodt Hospital Products Inc.
$32
Sandoz Inc.
$30
Medtronic USA, Inc.
$29
Aucta Pharmaceuticals, Inc.
$28
Almatica Pharma LLC
$28
BANNER LIFE SCIENCES, LLC
$26
Vanda Pharmaceuticals Inc.
$23
Avion Pharmaceuticals
$23
NS Pharma, Inc.
$22
Kedrion Biopharma, Inc.
$21
GE HealthCare
$19
Tactile Systems Technology Inc
$19
PORTOLA PHARMACEUTICALS, INC.
$18
SpringWorks Therapeutics, Inc.
$17
Inspire Medical Systems, Inc.
$15
Merck Sharp & Dohme Corporation
$14
TG THERAPEUTICS, INC.
$13
Arbor Pharmaceuticals, Inc.
$12
Piramal Imaging Limited
$11
Top 3 companies account for 14.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMYVID · ANDEXXA · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Albuked · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Betaseron · Briviact · CAMBIA · COPAXONE · DUOPA · Dhivy · Duopa · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · Equetro · Flexitouch Plus · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · Gamunex-C · Gralise · HORIZANT · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · INSPIRE · JANUVIA · KESIMPTA · KISUNLA · KYNMOBI · LATUDA · LEADPOINT · LEMTRADA · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · Motpoly XR · NAPRELAN · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONPATTRO · ONZETRA XSAIL · OXTELLAR XR · Ongentys · PANZYGA · PLEGRIDY · PONVORY · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · REXULTI · RYTARY · Rebif · Rystiggo · SOLIRIS · SPRIX · SYMPAZAN · Soliris · Spritam · TALTZ · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Tosymra Sumatriptan Nasal Spray · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VERCISE · VILTEPSO · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vercise · Vimpat · WATCHMAN Access System · XADAGO · XARELTO · XCOPRI · XEOMIN · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido · Zembrace · Zipsor
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
234
County median income
$117,588
Nearest hospital to ZIP centroid (approximate)
TEXAS HEALTH PRESBYTERIAN HOSPITAL PLANO
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Barta is a mixed practice specialist, with above-average Medicare volume (top 8% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Barta experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Barta performed 9,200 botox injection, per unit services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Barta receive payments from pharmaceutical companies?
Yes. Dr. Barta received a total of $21,829 from 99 companies across 1,068 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Barta's costs compare to other neurologists in Plano?
Dr. Barta's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Barta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Plano
Browse neurologists in Plano ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in TX
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in TX
Which TX neurologists receive the most from drug and device companies.
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology